Options Brief: Salix Pharmaceuticals (SLXP)

Shares of Salix Pharmaceuticals SLXP are higher on the session by 0.11%, trading at $43.96. Overall put volume is now running at 22.17x the daily average, with 4% of all puts traded being purchases on the offer. 1,530 contracts have traded on the session so far. Salix Pharmaceuticals, Ltd. is a specialty pharmaceutical company dedicated to acquiring, developing and commercializing prescription drugs used in the treatment of a variety of gastrointestinal diseases, which are affecting the digestive tract.